Dissecting Spesolimab's Approval With Boehringer Ingelheim's Carine Boustany
Business Of Biotech
00:00
Drug Discovery - What's Next for a Speciality Map?
Dr. Karim Busdani: Now more than ever, it's really an amazing time to be in drug discovery. The new types of molecules that we have right now in our hands are just amazing. I want to encourage every scientist who actually has an interest in drug discovery to explore that path because it is truly a unique time to be working in drug Discovery.
Transcript
Play full episode
